deltatrials
Recruiting PHASE1 INTERVENTIONAL 3-arm NCT06234423

A Study of CUSP06 in Patients With Platinum-Refractory/Resistant Ovarian Cancer and Other Advanced Solid Tumors

A Phase 1, First-in-Human Study of CUSP06, a Cadherin-6 (CDH6)-Directed Antibody-Drug Conjugate, in Patients With Platinum-Refractory/Resistant Ovarian Cancer and Other Advanced Solid Tumors

Sponsor: OnCusp Therapeutics, Inc.

Interventions CUSP06
Updated 11 times since 2024 Last updated: Jan 12, 2026 Started: Feb 9, 2024 Primary completion: May 30, 2027 Completion: Oct 31, 2027
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE1 trial investigates Ovarian Cancer and Solid Tumor and is currently actively recruiting participants. OnCusp Therapeutics, Inc. leads this study, which shows 11 recorded versions since 2024 — indicating substantial longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

~Feb 2024 – ~Mar 2024 · 29 days · monthly snapshot~Mar 2024 – ~Apr 2024 · 31 days · monthly snapshot~Apr 2024 – ~May 2024 · 30 days · monthly snapshot~May 2024 – ~Jun 2024 · 31 days · monthly snapshot~Jun 2024 – ~Jul 2024 · 30 days · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Apr 2025 · 7 months · monthly snapshotRecruiting~Apr 2025 – ~Jun 2025 · 2 months · monthly snapshot~Jun 2025 – ~Nov 2025 · 5 months · monthly snapshotRecruiting~Nov 2025 – ~Feb 2026 · 3 months · monthly snapshotRecruiting~Feb 2026 – present · 7 months · monthly snapshotRecruiting

Change History

11 versions recorded
  1. Feb 2026 — Present [monthly]

    Recruiting PHASE1

  2. Nov 2025 — Feb 2026 [monthly]

    Recruiting PHASE1

  3. Jun 2025 — Nov 2025 [monthly]

    Recruiting PHASE1

  4. Apr 2025 — Jun 2025 [monthly]

    Recruiting PHASE1

  5. Sep 2024 — Apr 2025 [monthly]

    Recruiting PHASE1

Show 6 earlier versions
  1. Jul 2024 — Sep 2024 [monthly]

    Recruiting PHASE1

  2. Jun 2024 — Jul 2024 [monthly]

    Recruiting PHASE1

  3. May 2024 — Jun 2024 [monthly]

    Recruiting PHASE1

  4. Apr 2024 — May 2024 [monthly]

    Recruiting PHASE1

  5. Mar 2024 — Apr 2024 [monthly]

    Recruiting PHASE1

    Status: Not Yet RecruitingRecruiting

  6. Feb 2024 — Mar 2024 [monthly]

    Not Yet Recruiting PHASE1

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • OnCusp Therapeutics, Inc.
Data source: OnCusp Therapeutics, Inc.

For direct contact, visit the study record on ClinicalTrials.gov .